This small-cap stock is expected to take off — if its weight-loss pill trial succeeds

Terns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnTerns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.nnDiscussion:nn” ai_name=”RocketNews A